Skip to main content

Advertisement

Table 1 Patient and treatment characteristics

From: Excellent local control and survival after postoperative or definitive radiation therapy for sarcomas of the head and neck

Table 1 n %   n %
Gender    Age   
Male 18 69 Median 64 years
Female 8 31 Range 19–88 years
Situation    Size   
Primary 22 85 Median 4.6 cm
Recurrent 4 15 Range 1–12 cm
Location    Grading   
Skull* 8 31 1 1 4
Sinus/orbit 7 27 2 8 31
Neck‘ 11 42 3 17 65
Histology    T stage   
Angiosarcoma 9 35 1a 4 15
MFH/undiff. pleo. 5 19 1b 10 38
Synovial 4 15 2b 12 46
Other 8 31    
N stage    CHT   
N0 24 92 Yes 13 50
N1 2 8 None 13 50
Clinical stage    Surgery   
Ia 1 4 R0 10 38
IIa 13 50 R1 6 23
IIb 4 15 R2 5 19
III 8 31 None 5 19
RT dose (PT)    ENI   
Median 66 Gy Yes 14 54
Range 45–72 Gy No 12 46
RT technique      
3D-CRT 17 65    
IMRT 7 27    
Electrons 2 8    
  1. *: includes skin, ‘: includes larynx/pharynx, MFH: malignant fibrous histiocytoma, undiff. pleo.: undifferentiated pleomorphic sarcoma, RT: radiation therapy, PT: primary tumor region, 3D-CRT: 3d-conformal radiation therapy, IMRT: intensity-modulated radiation therapy, cm: centimeter, CHT: chemotherapy, ENI: elective nodal irradiation (ipsilateral cervical nodes)